Search results
Results from the Tech24 Deals Content Network
Amarin (AMRN) closed at $17.90 in the latest trading session, marking a -0.11% move from the prior day.
Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q2 2024 Earnings Call Jul 31, 2024, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...
With primary care clinicians playing an ever-increasing role in the management of diabetes, staying on top of new developments in the American Diabetes Association’s (ADA) Standards of Medical ...
Amarin Corporation plc (formerly Ethical Holdings plc) was originally incorporated in England as a private limited company on March 1, 1989, and later re-registered as a public company on March 19, 1993. [9] In 2002, the company suffered losses worth $37 million; 2003 losses exceeded $19 million. [10] As of 2005, it was developing neurology drugs.
Analysts had anticipated the company to report $1.54 in earnings per share, generated from […] Today after the bell, Microsoft reported its calendar Q3 2020 earnings, the period of time that ...
A bull market had been in progress during this time, and now the underwriters were suggesting a price range of $17-$20 per share, but the preliminary prospectus indicated a possible offer price of ...
In June 2023, Inflection announced it had raised $1.3 billion to build what it called “more personal AI.”. The lead investor was Microsoft. Today, less than a year later, Microsoft announced ...
Barely a month ago, investors of Amarin (AMRN) were left dismayed following a lost patent trial against two generic drug makers seeking to sell their own versions of Amarin’s high triglycerides ...